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ABSTRACT 
Assessing the Performance Differences between Hospitals with and 
without Meaningful Use of Electronic Health Records on Care 
Outcomes 
Joseph G. Conte 
Seton Hall University, 2016 
Dissertation Chair: Terrence F.  Cahill, Ed.D. FACHE  
Background and Purpose of the Study: The U.S. healthcare system at $3 
trillion, is the sixth largest economy in the world.  The federal government is the 
largest purchaser of healthcare in the country.  In the past decade it has been on 
a quest to refocus its purchasing from volume to value.  While spending nearly 
double per capita than every other industrialized nation, U.S. healthcare 
outcomes are consistently in the lowest quartile for every major indicator from life 
expectancy to ambulatory sensitive conditions.  The Crossing the Quality Chasm 
Report (IOM) focused a lens on the dearth of electronic health record (EHR) 
systems nationally.  Resultant legislation, the HITECH Act, funded a $50 billion 
investment to close this gap along with promulgation of standards known as 
Meaningful Use (MU) to achieve interoperability.  This investment and related 
MU protocols for implementation warrant a careful examination to establish if the 
intended improved outcomes have been achieved. 
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  Methods: The study is a cross-sectional, retrospective design; it employs 
two cohorts, Meaningful Use (MU) vs Non-MU hospitals.  Publicly reported data 
on clinical outcomes, cost and safety from 4221 or 95% of the nation’s hospitals 
were included in the analysis to identify if there is a difference in outcomes 
between the hospital cohorts. 
  Results: 2315 of the 4221 or 55% hospitals who were included in the 
study met MU standards by 2013. The profile of an MU hospital was a non-
teaching (70%), geographically southern (40%), not-for-profit hospital (61%). 
Non-Mu hospital had a similar profile, 78% non-teaching, 35% Southern and 60% 
not-for-profit. Those hospitals who met MU had statistically lower mortality 
(p<.05) rates for all three clinical conditions (heart attack, heart failure, 
pneumonia) and statistically lower cost per discharge of $327 (p<.05). The 
improved outcomes suggest a reduced cost of over $6 billion and 21,000 fewer 
deaths.   
  Conclusion: The HITECH Act that committed over $50 billion in subsidy 
incentive funds has dramatically increased EHR adoption nationally from 8% in 
2009 to over 50% by 2013. The results from this suggest hospitals that had 
implemented EHRs’ that meet MU standards demonstrate mortality and cost 
outcomes that result in statistically significant cost and clinical care benefit. 
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CHAPTER 1 
INTRODUCTION 
BACKGROUND OF THE PROBLEM 
     The United States spends nearly double per capita what every industrialized 
nation does on health care per the Organization for Economic Cooperation and 
Development (Figure 1).  However, ranks in the lowest quartiles of performance 
for infant mortality, life expectancy, male and female healthy life expectancy and 
nearly every major health indicator (Figure 2).  These outcomes, coupled with an 
abysmal patient safety record (IOM, 1999; Bates, 2001; Shekelle, 2011) underlie 
systemic flaws in the system.  The need to identify effective levers for change 
began to evolve from government, industry and health economist in academia 
(Porter, 2006).  The gaps identified were not the absence of evidence based best 
practices, clinical guidelines, competent practitioners or academic rigor but a 
misaligned payment model and a dearth of electronic health records in the 
nation’s hospitals (IOM, 2001). 
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            Figure 2.  Healthcare Indicators - International vs U.S.   
In the search for solutions to the value inequity in American healthcare, the 
report “Crossing the Quality Chasm: A New Health System for the 21st Century” 
 
 
Figure 1.  Healthcare Spending Per Citizen Compared to U.S.   
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(IOM, 2001), focused national attention on electronic health records (EHR).  The 
report highlighted structural shortcomings of the existing healthcare delivery 
system, a major one being the “absence of real progress…toward applying 
advances in information technology” (p.  115). The report stated that all healthcare 
organizations should set goals for improvement, specifically that healthcare 
should be: safe, patient-centered, efficient, effective, timely and equitable.   In 
support of the IOM findings, the Health Information Technology for Economic and 
Clinical Health Act (HITECH) legislation was created to stimulate the adoption of 
health information technology.  This $50 billion investment, coupled with 
excitement generated by literature (Hillestad, 2005) that suggested that nearly 
$80 billion in savings would accrue from EHR adoption nationwide spurred a rush 
to EHR adoption (Desroches, 2013). 
   While electronic health record systems (EHR) existed in hospitals for 
decades, they functioned in isolation as departmental reporting and record 
keeping tools.  Laboratory, pathology, imaging, pharmacy and other ancillary 
programs without interconnectivity left valuable information isolated and 
inaccessible to multidisciplinary team users, resulting in excess utilization, 
ineffective prescribing and safety lapses (Bates, 2001).  An interconnected, 
cohesive electronic health record platform with access to the most current 
evidence base, clinical decision support and safety features to prevent errors was 
lacking in over 92% of hospitals as late as 2008 (DesRoches, 2010). 
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In addition to the focus on the EHR gap, payment reform is another lever 
being utilized to change the fundamental economics driving health cost, quality 
and the wide variations in care utilization trends (Fisher, 2009). The endgame in 
healthcare purchasing is not strictly one of cost control nor one of quality 
improvement in isolation; it is a search for value (Porter, 2006; McHugh, 2010). 
Value in healthcare is defined as health outcomes achieved per dollars spent 
(Porter, 2006).  Different models of payment reform such as Pay for 
Performance, Value Based Purchasing, Accountable Care Organizations (shared 
savings or risk models) and patient Centered Medical Home programs are all in 
play in the search for sustainable models balancing patient centered care with 
cost and quality outcomes (Eldridge, 2011).  Ultimately, value-based purchasing 
is part of a much broader policy “experiment” to advance value as a remedy for 
spiraling health benefit costs and quality concerns in US healthcare. The 
implementation of payment reform in parallel with the HITECH Act support for 
EHR has created a naturally occurring experiment in which to study the 
difference between hospitals that have adopted EHR technology and attested to 
Meaningful Use (MU) standards versus those that have not.  Meaningful Use is 
the set of standards for EMR adoption and functionality as defined by the Office 
of the National Coordinator (ONC). ONC not only defines the standards but also 
governs the assessment process employed to evaluate eligible providers’ and 
hospitals’ implementation progress to earn incentive payments. 
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The HITECH Act legislation committed a combined $50 billion in federal 
and state funds to support the rapid expansion of EHR capability in the nation’s 
hospitals and physician practices. The problem is that this legislation, while bold 
and strategic, was designed without empirical evidence that the investment 
would yield improved outcomes in population health, cost and safety. The belief 
that EHR adoption represents a significant component of the solution to modulate 
annual cost trajectory of healthcare and solve the quality and safety dilemma 
rests on conflicting research  which is at present inconclusive and depending on 
measurement parameters, time periods included and available survey data 
(Hillestad, 2005; Buntin, 2011; Blumenthal, 2010; Desroches, 2010; Rudin, 
2014).    
Further not only does the HITECH Act commit $50 billion in public funding, 
the criteria to earn the subsidy payments require substantial investments by 
hospitals and healthcare systems.  To obtain subsidy funding, which began in 
2011, healthcare providers had to demonstrate MU of electronic health records 
(EHR).  As stated above, MU is the set of standards for EHR adoption and 
functionality as defined by the Office of the National Coordinator (ONC).  ONC 
not only defines the standards but also governs the assessment process 
employed to evaluate eligible providers’ and hospitals’ implementation progress 
to earn incentive payments.   The opportunity to qualify for payments began in 
2011 for hospitals attesting to meaningful use standards.  In 2015, CMS began 
withholding between 1 and 3% of Medicare payments to those hospitals that 
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failed to meet the MU requirements.  It is estimated that the private funding 
required for the nation’s hospitals could top well over $100 billion (Rand, 2005) 
PURPOSE OF THE STUDY 
This study was undertaken to focus a lens on the impact of EHR adoption, 
a major health policy initiative under the HITECH Act (2009).  HITECH was 
implemented in parallel with Value Based Purchasing, the CMS program 
designed to realign payment with value and away from the fee for service 
structure focused on volume.   This study is needed because these 2 policy 
decisions created an intersecting impact on the healthcare system and have 
created a major gap in the literature that this study was designed to address.  
The purpose of this research therefore is to study whether there is a difference in 
publicly reported outcomes of quality, safety and cost per discharge between 
hospitals that have adopted EHR’s and achieved MU status versus those that 
have not achieved MU in the era of value based purchasing. 
As the healthcare payment system transitions to VBP, outcomes 
measures focusing on quality and cost are the key indicators to assess 
improvement and progress (VanLare, 2012; McHugh, 2010; Ranawat, 2009; 
James, 2012).   Prior studies focused solely on process measures for quality 
measurement.  These measures assess compliance with steps in care protocols, 
while a proxy assessment of quality (Donabedian, 1988, 2005; Mant, 2001) they 
do not align with current Value Based Payment models where hard outcomes 
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linked to expenditure such as readmission, cost per discharge, infection and 
mortality rates drive reimbursement schema.  Cost calculations were not 
standardized and therefore not comparable from study to study (Himmelstein, 
2009; Chaudry, 2006; DesRoches, 2010; Appari, 2009; Agha, 2011).  This study 
included safety, quality outcomes and cost per discharge measurements to 
assess whether MU adoption of EHR systems makes a difference in these 
outcomes. 
  Numerous studies (Himmelstein, 2009; Chaudry, 2006; DesRoches, 2010; 
Appari, 2009; Agha, 2011) have demonstrated that EHR adoption has a generally 
positive impact on process measures of quality.   Most however, have found 
negative to neutral outcomes on cost of care.  Much of this research was 
conducted prior to the creation of MU criteria (Himmelstein, 2009; Chaudry, 2006) 
or standardized cost per episode of care.  This gap indicates that this research 
approach, outcome vs process is necessary to more closely focus a lens on how 
MU standards can improve cost and value as organizational maturity and 
experience with EHR evolves.   
Therefore, in the context of value based purchasing (VBP), the secondary 
purpose of the study is to utilize outcome measures such as mortality, 
readmission and cost per episode of care linked to Value Based Payment models 
as opposed to process measures to evaluate the differences in performance in 
clinical quality and cost.  These and other outcome measures are the foundation 
of payment under the VBP methodology.  The challenge to the validity of the 
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program is utilizing reliable quality indicators and a sound cost rubric (Wachter, 
2006; Rudin, 2014, Kazley, 2009).  Therefore, an underlying goal of this study is 
to bring a level of consistent outcome measurement to the literature in the MU 
era.  This will stand in contrast to the inconsistent and complicated systems of 
performance measurement previously applied when comparing results between 
organizations outcomes and their MU status. 
 
  Study Variables 
The independent variables selected for this research have been utilized 
consistently in the literature focusing on EHR adoption (Chaudry, 2006; Jha, 
2009; Himmelstein, 2009; Agha, 2011; Ding, 2011; DesRoches, 2013).  The 
variables are teaching status, case mix index (CMI) or acuity, region, discharge 
volume and owner status (Table 1).   Teaching status describes whether a 
hospital participates in graduate medical education of physicians as defined by 
Council of Teaching Hospitals and Health Systems (COTH).  Teaching hospitals 
characteristics include tendency toward more complex care, service for the 
underprivileged, greater cost per discharge and urban locations (Shahian, 2014).   
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Table I: Study Variables  
          © 2016 Joseph G.  Conte 
         
Case mix is an extremely important variable in that it reflects the 
complexity of care across various diagnostic related groups (DGR), but also 
includes factors that account for regional variation in cost of services.  DRG are 
assigned by the primary reason for hospital care but also include a patient’s age, 
sex race as well as co-morbidities.  Co-morbidities are pre-existing medical 
conditions that affect how care is provided and ultimately weigh on the total cost 
of service and likelihood of a favorable outcome of care.  CMI is represented as a 
numeric value with a normalized base of 1.0.  This represents the “average 
hospital” CMI, a value greater than 1.0 reflects higher complexity of care and cost 
of service, with the opposite holding true.  In the VBP context CMI is a very 
important hospital factor for reimbursement. 
25 
 
Region is a geographic construct coded 1-4 applied to mirror the 4 regions 
recognized by the Center for Medicare coding system.  Discharge volume 
reflects total number of cases discharge from the hospital included deaths.  
Obstetrical and pediatric cases are not included in Medicare calculations.   
Ownership status falls into the three categories, not-for-profit, for-profit, 
governmental.   
In order to address cost, quality and safety measurements, the dependent 
variables for this study are cost per inpatient discharge, morbidity and mortality 
rates for heart attack, heart failure and pneumonia and a standardized patient 
safety score (Table 2).   
Table II: Dependent Variables 
© 2016 Joseph G.  Conte 
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Research Questions 
These are the five research questions: 
  Is there a difference in clinical outcomes between hospitals that have 
achieved Meaningful Use (MU) for their EHR systems verse hospitals that have 
not achieved  MU as measured by mortality and readmission rate for Heart 
failure? 
  Is there a difference in clinical outcomes between hospitals that have 
achieved Meaningful Use (MU) for their EHR systems verse hospitals that have 
not achieved  MU as measured by mortality and readmission rate for Heart 
attack? 
  Is there a difference in clinical outcomes between hospitals that have 
achieved Meaningful Use (MU) for their EHR systems verse hospitals that have 
not achieved  MU as measured by mortality and readmission rate for Pneumonia? 
       Is there a difference in clinical outcomes between hospitals that have 
achieved Meaningful Use (MU) for their EHR systems verse hospitals that have 
not achieved  MU as measured by Agency for Healthcare Research and Quality 
Patient Safety Indicator  
Measurement? 
   Is there a difference in cost per discharge between hospitals that have 
achieved Meaningful Use (MU) for their EHR systems verse hospitals that have 
not achieved as measured by the CMS standardized cost per discharge metric? 
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Significance of the Study 
  There are over 4000 hospitals in the US confronted by what is essentially 
a federal mandate to achieve MU adoption of their EHR systems, i.e.  incur 
penalties for non-adoption of 2% of gross Medicare revenue by 2016.  Given the 
magnitude of the investment required by hospitals and the $50 billion in 
governmental subsidy available to transform healthcare in the US to an 
interoperable EHR platform objective measurement of its efficacy is essential.  
This study applies outcome not process measures that align with core VBP 
indicators to evaluate whether EHR adoption under the MU guidelines can 
achieve the promise of quality, cost and safety improvement highlighted in the 
Crossing the Quality Chasm report (IOM, 2001). 
  In 2015, over $1.5 billion was withheld from hospitals that failed to achieve 
the specified performance outcomes and then reallocated to hospitals based on 
their overall performance on a set of outcome measures in clinical, cost and 
satisfaction measures (www.cms.gov/VBP).  The paradigm shift of moving away 
from paying for volume of services to linking payment with outcomes for the 100 
million Americans covered by Medicare is transformational.  This is the most 
significant change in US healthcare since government sponsored health 
insurance came into being.  Because commercial Medicare managed care plans 
and Medicaid programs in each of the states are adopting this very same payment 
methodology, the influence of value based purchasing in US healthcare is an 
attempt at transformation on a grand scale (VanLare, 2012; Eldridge, 2011).   
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Operational Definitions 
  There are three main constructs used in this study that are identified in the 
literature.  These three constructs are Meaningful Use, Value Based Purchasing 
and Quality/Outcomes Measurement.  Meaningful Use (MU) refers to the criteria 
developed by the Office of the National Coordinator (ONC) that defines the 
interconnectivity standards and technical performance requirements necessary to 
achieve MU designation under one of the three progressive levels to be eligible 
for federal subsidy payments.  Value-based purchasing (VBP), links payment 
directly to the quality of care provided, it moves the focus from volume to value 
(Porter, 2009).  CMS has made VBP (www.cms.gov/Medicare/Quality-Initiatives) 
the focus of its effort under the Affordable Care Act, to transform the current 
payment system by rewarding providers for delivering high quality, efficient clinical 
care based on value, not volume.  The methodology most favored when 
assessing quality of care in the hospital setting has been to use process 
measures (Donabedian, 1988).  The shift to outcome measures like mortality, 
readmission, infection rates, etc.  has occurred in parallel (VanLare, 2012; 
Ranawat, 2009; Porter, 2009) with the need to shift from adherence to standards, 
to risk adjusted outcomes of care where value not volume is the driver. 
CONCEPTUAL MODEL 
   The measurement of outcomes is at the core of the analysis to determine 
if there is a relationship between MU adoption of EHR systems and improvements 
regarding quality of care and/or safety, and/or cost of care.” This study draws on 
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two theoretical frameworks, one focused on clinical care measurements and the 
other focused on healthcare economics.  The Donabedian Model is the dominant 
paradigm for assessing the health care.  It focuses on structure, process and 
outcome to measure quality.  The second is the Value Based Purchasing theory 
advanced by an economist Michael Porter in his seminal work, Redefining 
Healthcare (2006).  The Porter model argues that the US healthcare system’s 
inherently misaligned payment methodology resulted in the pursuit of high 
volume, high margin services without a focus on the outcomes of health for the 
population being served or the total cost of care incurred.   
  The successful adoption of EHR’s under the Meaningful Use (MU) criteria 
developed by the CMS Office of the National Coordinator is based upon 
achieving, both process and outcome milestones.  The Donabedian model 
therefore is uniquely suited to function as an overall theoretical model as it 
incorporates the assessment of multiple process steps to achieve MU while at the 
same time including the care outcomes as a core domain.  How the domains of 
EHR implementation processes and measures for the outcomes of quality and 
cost of care align to form the theoretical measurement approach to assess the 
difference in outcomes for MU and non-MU hospitals is illustrated in Figure 3.   
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 Figure 3.  Application of Donabedian Model Assessment of EHR   
 © 2016 Joseph G.  Conte 
  Figure 3 illustrates the Donabedian structure, process, outcome matrix as 
applied in this study to EHR adoption.  Under structure, it encompasses the 
physical facility, equipment, and human resources, as well as organizational 
characteristics such as staff training and payment methods.  The Process 
elements include technical processes for EHR implementation, compliance with 
ONC criteria under MU and provision of services influenced by EHR protocols.  
And of course the outcome domain contains all the effects of healthcare on 
patients or populations, including changes to health status, behavior, health-
related quality of life.  This theoretical model, while oriented to process measures 
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as proxies for outcomes such as achieving MU status process criteria, is also as 
flexible enough to incorporate outcome indicators into measurement criteria.   
  In fact, nearly thirty years ago Donabedian (1988) made an astute 
observation that is at the core of the dilemma of the inexorable cost trajectory in 
healthcare.  He noted that “it is believed that as one adds to care, the 
corresponding improvements in health become progressively smaller while costs 
continue to rise unabated” (p.  1745).  Consistent with current payment reform 
focus on value, he postulated that it is possible to separate quality from 
inefficiency by analyzing each added bit of expected usefulness against its 
corresponding cost.  Those providing care without regard to cost, he terms 
maximalist.  Those who provide care with a focus on weighing each additional bit 
of expected usefulness against its corresponding cost, he terms optimalist.   
  Donabedian captures the essence of current healthcare reform debate by 
focusing on the maximalist vs optimalist approaches to care and their respective 
impacts on cost and health benefits.  This value dilemma, excessive cost coupled 
with inferior population health and safety outcomes, positions the US healthcare 
system to search for systemic, effective solutions.  What the Donabedian model 
lacked was an economic framework to embody this concept into a system with 
functional regulatory and financial underpinnings.  This is where the work of Porter 
with its emphasis on value, cost and outcome created the underpinning for the 
value based purchasing paradigm. 
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   Porter’s seminal work Redefining Healthcare (2006) focused on the 
misaligned reimbursement model as the root cause for out of control cost and 
poor health outcomes.  He highlighted how the entrenched pay for volume rather 
than payment for value system encouraged high cost, high volume care rather 
than a focus on population health.  In Figure 4.  the change associated with 
current to future state evolution in VBP is represented.   
        
 
   Figure 4.  Current State vs.  Future State Evolution in VBP   
          Source: New York State Value Based Roadmap, 2015 
   Porter also rejected reliance on compliance with process measures as an 
effective measure system to govern reimbursement methodology preferring the 
IHI inspired Triple Aim (IHI, 2006) outcome measures rubric.  The current VBP 
system informed by Porter’s work has shifted reimbursement from former pay for 
volume to a focus on outcomes of care and total cost of service.  After a transition 
33 
 
period, 2011-2013, where process measures dominated payment, outcomes of 
care and cost now account for 90% of reimbursement for the program in 2016.   
   These two conceptual models, the Donabedian triad model of structure, 
process and outcome, coupled with the Porter value based payment model are 
the theoretical pillars adopted by this study to measure the impact of EHR 
systems on hospitals.  In order to bring a more detailed focus on the research to 
date as well as the theoretical concepts and developments of EHR 
implementation in the MU era, the literature on the topic is reviewed in the next 
Chapter.   
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Chapter II 
    LITERATURE REVIEW     
The early excitement on the potential quality and cost improvements benefits, 
associated with EMR adoption was fueled by literature funded by the Rand Corporation 
(Hillestad, 2005) that suggested that nearly $80 billion in savings would accrue from 
EHR adoption nationwide.  This estimate was based on savings associated with 
efficiency, clinical decision support and safety improvements.  When added to the 
anticipated savings from improvements in preventative and chronic disease 
management the estimated benefit increased to the $100 billion level.   
Prior to the adoption of the HITECH Act (2009), which included over $50 billion in 
federal Meaningful Use (MU) funding, the US seriously lagged other industrialized 
nations in EMR adoption.  In 2008, prior to the advent of MU incentives, fewer than 9% 
of US hospitals had even basic EMR systems (DesRoches, 2013).  The benefit of MU 
incentives and threat of penalties (HITEC Act, 2009) jump started EMR adoption and by 
2010 the proportion of US hospitals with basic EMR jumped to 15% (DesRoches, 2013).  
Once financial incentives under MU began flowing in 2011, the adoption of EHR 
systems nearly doubled to 27% (AHA IT Survey, 2013).  The American Hospital 
Association data (IT Survey, 2013) identified that EHR adoption was most robust in 
large urban and teaching hospitals. 
 As the $30 billion HITECH Act (2009) subsidy to stimulate EHR into US 
healthcare over the past 10 years has accelerated, the effort to assess its effectiveness 
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has grown.  However, the literature (Chaudry, 2006; Himmelstein, 2009; DesRoches, 
2010; Ding, 2011; Appari, 2012) that has investigated the association between the 
investment in EHR and its effect on quality, safety and cost domains reveal mixed 
results at best.   Individual hospital, ambulatory practice and even health system 
reviews illustrate improvements in domains such as medication safety (Bates, 2001; 
Poon, 2012) or quality scores (Lindenauer, 2007), yet the results are far from 
conclusive.  Other recent studies have demonstrated little if any benefit in quality and 
none in cost control (Ding, 2011; Himmelstein, 2009).   
Appari, et al. (2012) reviewed HIT and quality data for a four year period (2006-
2010) for 3,921 non-federal hospitals.  They measured quality by analysing process 
measure compliance for pneumonia, heart attack and heart failure.   Statistical analysis 
was conducted using fixed effects linear panel regression models over a 5 year period, 
2006-2010.  Their study entitled "Meaningful Use of Electronic Health Record Systems 
and Process Quality of Care: Evidence from a Panel Data Analysis of U.S.  Acute-Care 
Hospitals”, found adoption of EHRs did improve hospital process quality measures for 
AMI, heart failure and pneumonia.  This improvement was especially true for hospitals 
that started with scores in the lowest quartile of performance.  In an unexpected finding, 
hospitals with EHRs that upgraded their basic systems to more advanced functionality 
experienced a quality score decline.  This finding prompted a cautionary conclusion 
“technology implementation alone is not sufficient to produce quality improvement” (p.  
17).  As stated earlier, a limitation in this and other studies is that it was conducted 
before MU criteria were codified by the Office of the National Coordinator.  Their 
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evaluation of MU compliance was based on self-reported capabilities from the AHA 
annual IT survey not assessment of MU compliance as required under the HITECH Act 
(2009).  Neither cost nor safety was included in the analysis critical factors when the 
value of services are evolving into central theme in healthcare policy. 
Spencer (2010) utilized a national cohort study based on primary survey data 
about hospital EHR capability and publicly reported quality data.  A regression analysis 
was used to assess the relationship between EHR adoption and quality improvement for 
heart attack, heart failure and pneumonia care.  To evaluate the association between 
quality improvement over time and the availability of an EHR, they compared hospitals 
that maintained a system with those that reported having no system.  The results were 
striking for significant increase in quality scores for heart failure, less for heart attack 
and none for pneumonia scores.  Unlike the findings from the Appari, et al. (2012), 
implementation of advanced systems did not result in decreased quality scores but did 
result in smaller gains for AMI and heart failure. 
Ding et al., (2011) examined the effects of EMR on the clinical, financial and 
operational outcomes of U.S. hospitals.  They utilized publicly reported data on EHR 
adoption from 2006-2008 (the pre-MU era).  The information was obtained from the 
Health Information Management (HIMSS) database, the Hospital Quality Alliance for 
quality scores and the American Hospital Association database for performance 
metrics.  The focus of the study was to test the effects of EMR adoption over time within 
a hospital.  This is a unique analysis moving away from EMR adoption as a binary 
variable, i.e.  EHR vs no EHR, to one looking at the effect of the adoption overtime.  
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Using simultaneous regression models they found that EMR adoption has a positive 
and significant effect on cost and quality.  Specifically, adoption history, the time an 
organization was operational with an EMR, was associated with reduced cost per 
patient day but not on length of stay.  Therefore, overall cost per discharge were 
essentially unchanged.  The improvement in process quality measures for AMI, heart 
failure and pneumonia clinical outcomes likewise increased over time.  When comparing 
the effect size, they found the impact on operational and financial outcomes more 
significant than that on clinical quality measures.   
            Himmelstein (2009) linked data from an annual survey of computerization at 
approximately 4,000 hospitals for the period from 2003 to 2007 with administrative cost 
data from Medicare Cost Reports and cost and quality data from the 2008 Dartmouth 
Health Atlas.   Higher overall computerization scores correlated weakly with better 
quality scores for acute myocardial infarction (r_0.07, P_.003), but not for heart failure, 
pneumonia, or the 3 conditions combined.  Utilizing multivariate analyses, more 
computerized hospitals had slightly better quality.   However, in comparing a hospital’s 
overall computerization score, more computerized hospitals had higher total costs in the 
2003-2007 period and a more rapid increase in computerization was associated with a 
faster increase in computerization costs.   Himmelstein, et.al (2009) concluded that as 
currently implemented, hospital computing might modestly improve process measures 
of quality but does not reduce administrative or overall costs.  Further, hospitals that 
increased their computerization more rapidly had larger increases in administrative 
costs.  As significant federal and state financial resources continue to be committed to 
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EHR adoption, the investments, as per Himmelstein, “rest on scant data” and “Recent 
Congressional Budget Office reviews have been equally skeptical…” (pg. 2). 
Value Based Purchasing 
Payment reform is a lever being utilized to change the fundamental economics 
driving health cost, quality and wide variations in care utilization trends (U.S Department 
Health and Human Services, 2007; Eldridge, 2011).  The endgame in healthcare 
purchasing is not strictly one of cost control nor one of quality improvement in isolation; 
it is a search for value.  This means a movement away from payment for volume to one 
of payment to reward quality outcomes that contain cost.  Different models of payment 
reform such as Pay for Performance, Value Based Purchasing, Accountable Care 
Organizations (shared savings or risk models) and patient Centered Medical Home 
programs are all active strategies in a search for sustainable models balancing patient 
centered care with cost and quality outcomes (James, 2012; VanLare, 2012)  
Ultimately, value-based purchasing is part of a much broader policy “experiment” to 
advance value as a remedy for spiraling health costs and quality concerns in US 
healthcare.   
Regardless of the vehicle(s) chosen, until incentives to providers are aligned in 
local or regional arrangements with population health as an ultimate measure of value, 
the current siloed approach under fee-for-service will continue to promote perverse 
resource utilization (VanLare, 2012).  As demonstrated over the past 20 years by 
Dartmouth Atlas reports (Fisher, 1999) regional variation in health care costs have no 
correlation to differences in quality outcomes, acuity of care or cost of care delivery.  
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The report identified that in high cost regions (Fisher, 2009) utilization patterns by 
physicians and others respond to the availability of high cost alternative services that 
have no greater efficacy, including discretionary referrals to specialists.  The payment 
for volume of services provided which was the predominant model by which 
discretionary service was delivered resulted in high cost care with no quality difference. 
The current system of care drives destructive competition not competition on 
value (Porter, 1999).  Pro-competitive and outcome oriented care such as Value-based 
purchasing (VBP), links payment directly to the quality of care provided, it moves the 
focus from volume to value (Porter, 2009).  Based upon similar mounting evidence 
regarding the unsustainable cost trajectory and lack of association with value, CMS has 
made the focus of its efforts to transform the current payment system by rewarding 
providers for delivering high quality, efficient clinical care (James, 2012; Affordable Care 
Act, 2010 ).  Through a number of public reporting programs, demonstration projects, 
pilot programs, and voluntary efforts, CMS has launched VBP initiatives in hospitals, 
physician offices, nursing homes, home health services, and dialysis facilities (CMS 
Hospital Pay-for-Performance Workgroup, 2007).  In 2006, Congress passed the Deficit 
Reduction Act of 2005 (DRA), which authorized CMS to develop a plan for VBP for 
Medicare hospital services commencing FY 2009.   
An early effort at incentives for publicly reporting process quality measures was 
Medicare’s Reporting Hospital Quality Data for Annual Payment Update (RHQDAPU) 
program.  This is a pay-for-reporting (P4R) program that uses Medicare payment as an 
incentive for hospitals to publicly report on the care they provide all adults, regardless of 
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payer.  As originally mandated under the 2003 Medicare Modernization Act (MMA), the 
RHQDAPU provision required that PPS hospitals report on a specified set of 10 clinical 
performance measures in order to avoid a 0.4 percentage point reduction in their 
Annual Payment Update (APU) for inpatient hospital services.  This is the source of the 
self-reported quality data for the Hospital Compare website, www.hospitalcompare.gov.   
Payment reform has resulted in multiple reimbursement methodologies being 
experimented with to identify provider preference and reduced cost.  These include 
bundled payments programs (innovation.cms.gov/initiatives/bundled-payments) where a 
group of providers split a single payment by episode of care.  Examples include joint 
replacement or cardiac surgery have shown promise (VanLare, 2012).  The Geisinger 
coronary bypass program, known as ProvenCare, is designed as a flat fee payment for 
surgery and all related care for 90 days after discharge.  At Geisinger health care 
system, these programs demonstrated a 10% reduction in readmissions, shorter 
average length of stay, and reduced hospital charges.  Perhaps most importantly, the 
program achieved a 44% drop in readmissions over a course of 18 months (Bertko, 
2010). 
When P4P objectives are aligned with national best practice evidence as in the 
CMS/Premier Quality Incentive Demonstration (HQID), process quality measures 
improved significantly over a matched control group of non-participating hospitals 
(Lindenauer, 2007).  The study enrolled 266 participants in the HQID who were 
matched with 406 Hospital Quality Alliance (HQA) controls.  Hospitals needed to have a 
minimum of 30 cases per condition (heart failure, heart attack, pneumonia, cardiac and 
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orthopedic surgery measures) annually to be eligible for the demonstration.  For each of 
the clinical conditions, hospitals performing in the top decile on a composite measure of 
quality for a given year received a 2% bonus payment in addition to the usual Medicare 
reimbursement rate.  Hospitals in the second decile received a 1% bonus.  Bonuses 
averaged $71,960 per year and ranged from $914 to $847,227.    A participation 
requirement was that all hospitals accept a risk of financial penalty.  These penalties 
ranged from 1 to 2% of Medicare payments for the conditions under evaluation.   They 
applied if by the end of the third year of the program they ranked in the lowest two 
deciles of hospitals.  This is one of the earlier programs in which providers 
demonstrated a willingness to accept risk based agreements (CMS, VBP, 2010) this is 
an important but largely forgotten fact. 
Gain sharing, once controversial but now in popular use, is another approach to 
reward incentivized behavior.  Gainsharing arrangements, particularly those used in 
hospital and integrated delivery systems, provide bonus payments to physicians and 
other providers, to reward cost savings resulting from their efforts to reorganize delivery 
of clinically appropriate care at a lower cost (Eldridge, 2011).  The benefit for Medicare 
is that CMS shares in 50% of the reduced payments.  Accountable Care Organization 
(ACO) type programs, where total cost of care for a population is assigned to the 
participating practitioners, has now evolved more towards a value based paradigm.  In 
the new ACO/gain sharing scenarios providers now have down side risk if they 
overspend the funds allocated to their population which often is calculated as the prior 3 
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year average per capita spend  (https://www.cms.gov/Medicare/Medicare-Fee-for-
Service-Payment/ACO/index.html). 
Regardless of the foregoing, Porter (2006) is critical of payment reform 
methodologies such as P4P which do not seek to keep the focus on value.  He criticizes 
their emphasis on compliance with evidence based guidelines and algorithms because 
they lack focus on outcomes of care such as readmission, mortality, cost per discharge, 
etc.  More important is that they do not discourage excess utilization.  Donabedian 
described clinicians as maximalist when their approaches to incremental care result in 
little change in outcome, Porter expressly discourages reward for P4P in these 
programs.  A financing incentive linked to process measure improvement, P4P, rewards 
providers for achieving pre-established performance objectives in defined medical 
conditions and procedures.  However there is some evidence that at least process 
quality improved in at least one large national study (Lindenauer, 2007).   
 
 
PROCESS VERSUS OUTCOME - ASSESSING QUALITY IN THE MEANINGFUL USE 
& VALUE BASED ERA 
 The correct method to select in order to objectively assess quality and cost 
outcomes, the two basic components of the value equation, remain very much in 
debate.  The current practice for evaluating EMR impact on healthcare is the analysis of 
its impact on cost and quality.  The most widely applied method to evaluate quality 
performance is the use of process measures (Donabedian, 1988; Mant, 2001; Mainz, 
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2003; Lilford, 2007).  However, as Pronovost (2004) notes, the IOM defines quality as 
“the degree to which health services for individuals and populations increase the 
likelihood of desired health outcomes (emphasis added) and are consistent with current 
professional knowledge.” As CMS enters its third year of the Value Based Payment 
Program for Medicare (CMS, 2010) the focus is clearly on cost and outcome measures.  
The emphasis on process measures has diminished from 60% to 10% of the 
reimbursement methodology.  Numerous proponents (VanLare, 2012; Ranawat, 2009; 
Porter, 2009) of the outcome measures emphasize the need to shift from mere 
adherence to standards, to risk adjusted outcomes of care where value not volume is 
the driver. 
 However, from the clinical standpoint Liford (2007) and Mant (2001) support the 
contrary premise that process measures are direct measures of the quality of health 
care, provided that a link has been demonstrated between a given process and 
outcome.   In addition, they advocate for process measures because they are well 
defined, easily measured, sensitive, specific and easy to interpret.   Their construct 
validity is derived from professional societies such as American Heart Association, 
American College of Cardiology, etc.  and therefore well vetted and form the community 
standard of practice.  The controversy of process versus outcome measures is a 
consistent theme of quality literature (Pronovost, 2004; Mant, 2001; Liford, 2007).  The 
acuity of patient’s conditions, their compliance with care plans, their financial and 
sociologic backgrounds, referred to as social determinants of health, all influence 
important outcomes such as readmission, mortality and control of chronic disease.  In 
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these circumstances it would be as Mant (2001) notes a “misnomer” to refer to outcome 
measures as performance indicators since this would indicate a “barometer” of 
population health.   In an insightful and pertinent reference to the usefulness of outcome 
measures, Mant notes outcome data should be used to “inform upon wider aspects of 
health policy”, which Value Based Purchasing is a central theme.  (p.  479)   
 The current reliance on process measures is not based solely upon concerns 
with the potentially confounding factors referenced above.  Experts in quality have 
postulated that the triad of structure-process-outcome forms the foundation of quality 
improvement processes.   Donabedian (1966, 1988), a practicing physician, 
emphasized the importance of both process and outcome measures.  He stated “we 
cannot claim either for measurement of process or measurement of outcome an 
inherently superior validity, since the validity of either flows to an equal degree from the 
validity of the science that postulates a linkage between the two.  But process and 
outcome do have, on the whole, some different properties that make them more or less 
suitable objects of measurement for given purposes” (p.  1746).    
 Mainz (2003), also supports a strategy to employ both process and outcome 
measures depending on the purpose.  Process measures are especially useful when 
quality improvement initiatives are being initiated as they can be applied to small 
samples and are sensitive to small differences making them desirable for departmental 
and local analysis.  The foundation of the application of these measures is that they be 
valid, requiring rigorous testing to produce the desired outcome, which he refers to as 
“outcome validated”, and therefore represent direct measures of quality.   
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 Outcome measures are more suited to assess the effectiveness of process and 
as end points of care (Lilford, 2007; Mant, 2001).  Examples of hospital specific 
outcome measures include mortality, infection and readmission rates.  However, 
outcome measures have the added feature of being able to encompass broad public 
health measures such as cancer, influenza and cardiac disease prevalence.  As Mainz 
(2003) notes, it can be recommended that the broader the perspective required, the 
greater the relevance of outcome indicators.” (p. 527) It is therefore not surprising that 
CMS, as the largest payer of healthcare in the United States, has moved towards the 
implementation of outcome measures as a yardstick for quality performance and 
payment. 
Table III: Examples of Indicators Related to Structure, Process & Outcome  
© 2016 Joseph G. Conte 
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 Illustrated in Table III are indicators for conditions such as stroke, asthma, heart 
attack care, women’s health and ICU care.  What can be discerned from each of the 
indicators is the continuity between the structural component, the process to be 
employed and the desired outcome to be achieved.   As Mainz (2003) astutely 
observed, process measures are especially usefully for evaluating compliance with 
standards of care and feedback on departmental performance.  The outcome measures 
on the other hand, are more a check on the effectiveness of the implementation of the 
standards and broader public health or policy objectives that are desired to be achieved.  
CMS, the largest payer of health care in the three trillion dollar U.S. health system, has 
evolved from a passive payer of services to a more demanding consumer seeking to 
achieve a balance between cost and quality; hence the advent of Value Based 
Purchasing Program  (Federal Register, 2011). 
SUMMARY OF THE LITERATURE TO DATE 
 There are three distinct but related areas of literature being utilized to inform the 
parameters of study on EHR impact on quality cost and outcome.  They are literature 
that assess the impact EHR adoption has on healthcare performance, literature that 
utilizes differing measurement philosophies to measure performance (process vs 
outcome) and the literature on the payment reform programs.    
 While the need to improve quality and safety outcomes is of paramount 
importance (IOM, 1999; IOM 2001) the $3 trillion cost associated with the U.S. 
healthcare systems is an unsustainable financial burden for the government (Porter, 
2006; Darling, 2010)) and individuals (Polsky, 2009).  The need to clearly identify what, 
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if any, cost savings can be associated with the adoption of EMR under MU guidelines, 
has therefore received great attention.  The review of the payment reform literature 
details the shift away from fee for service or volume based care to payment for value 
(Porter, 2006; Ranawat, 2009; Eldridge.  2011; James, 2012; VanLare, 2012).  One 
focus of this study will be to identify what if any connection exists between EHR 
adoption and improved cost.  As previously noted numerous studies (Himmelstein, 
2009; DesRoches, 2010; Appari, 2009; Agha, 2011) have demonstrated that EMR 
adoption while having generally positive impact on process measures of quality have 
negative to neutral outcomes on cost of care.    
GAPS IN THE LITERATURE 
 To make the connection between EHR adoption, MU standards and shift towards 
value and improved outcomes a measurement redesign is required.  The underpinning 
of the EHR literature analysis conducted to date has been the reliance on process 
measures to assess performance difference on quality, safety and cost (Chaudry, 2006; 
DesRoches, 2010: Buntin, 2011; Jones, 2014).  Whether compared within or between 
hospitals before and after EHR adoption or between hospitals that have or have not 
adopted the technology, reliance on process measures has been the standard 
measurement rubric.  This method while accepted professionally (Donabedian, 1988; 
Mant, 2001; Mainz, 2003; Lilford, 2007) is in direct conflict with the measurement 
paradigm used for the various VBP payment models.  Since the parallel lever for 
healthcare transformation, payment reform, is being simultaneously implemented with 
MU standards for EHR adoption the linkage with outcomes that influence direct cost 
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such as cost per discharge, readmission, preventable ER use, complication rates, etc.  
Further the cost variable used from study to study was inconsistent with some study 
using cost estimates derived from annual cost reports (Himmelstein, 2009) or financial 
and operational data from the American Hospital Directory (Ding, 2011).  The fact that 
much of this research was conducted prior to standard MU definitions being available, 
i.e. the pre-MU era, also confounded reliability of the adoption stage of EHR technology 
estimated by hospitals.  None of the estimates of adoption were based on the MU 
criteria and all data was based on survey responses which at best resulted in 50% 
response rates.  This lack of consistency between studies dictates that continued 
research is necessary to more closely focus a lens on how MU standards for 
interoperability, provider order entry (CPOE), and decision support can improve cost 
and value as organizational experience with EMR evolves (Ding, 2011).   
 The gaps that this study will address impact both methodological and analytical 
domains.  Previous studies ignored the advent of value based purchasing on the 
measurement paradigm.  No prior study utilized the actual achievement of MU status as 
measured by CMS as a sorting method to cohort MU and non-MU hospitals.  Early 
approaches relied on incomplete and self-reported survey data applying a HIMSS 
electronic health record functionality algorithm.   Another major methodological gap this 
study will bridge is the prior approach to measure quality.  When assessing the impact 
EHR had on clinical performance prior studies relied solely on process measures not 
outcome measures.  This study also bridges the gap between the prior studies that 
used non-standardized cost measures.   
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 The question to be explored in this research is whether achieving meaningful use 
status (MU) of EHR technology is associated with achieving a more favorable 
relationship between cost, safety and improved healthcare outcomes.  The difference 
between this study and prior research that attempted to make this connection is that this 
study will use standardized cost values calculated by the CMS which risk adjust for 
acuity, regional cost variation and teaching status.  Therefore, all cost values will be 
uniform and consistent between hospitals.  In addition, all MU criteria will be judged by 
the ONC criteria for MU standards so that each response is internally valid and 
consistent between hospital responses.   In prior research, self-reported survey data 
with response rate as low as 50% were used to rank MU performance.  This study will 
not be affected by survey response bias since all hospitals must respond to achieve 
their MU incentives and those that do not are automatically categorized as non-MU.   
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Chapter III 
RESEARCH METHODS 
RESEARCH DESIGN 
 The study is a cross-sectional, retrospective design; it employs two cohorts, 
Meaningful Use (MU) vs Non-MU hospitals.  This research seeks to assess the impact 
of EHR adoption on publicly reported outcomes for quality, safety and cost in the value 
based purchasing era.  As many as half of U.S.  hospitals (DesRoches, 2013) did not 
have a basic EHR system as of 2012 and far fewer had attested to MU standards.  The 
implementation of healthcare payment reform as a component of the Affordable Care 
Act (ACA) in parallel with the HITECH Act created a naturally occurring experiment in 
which to study the difference between hospitals who have adopted EHR technology and 
attested to MU standards versus those who have not but have been equally impacted 
by the Value Based Purchasing program without attesting to MU with EHR adoption, the 
independent variable.  Since there was no human subjects or individual level personal 
health information the Seton Hall Institutional Review Board (IRB) concluded that the 
study did not fall under the requirement for IRB review (See Appendix A).    
Sample 
Two cohorts were created from the Center for Medicare and Medicaid Services 
(CMS) Hospital database. One cohort will represented hospitals that had not attested to 
the MU adoption of certified EHR technology as of 2013.  The second cohort were 
hospitals that had attested to MU.  For this study, data on EHR adoption followed strict 
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inclusion criteria for meeting MU adoption standards promulgated by the Office of the 
National Coordinator (ONC). The actual records were drawn from the CMS payment 
documentation file that records which hospitals received meaningful use payments and 
in what years it was paid. Therefore, there was no need for proxy mapping (Appari, 
2012; Furukawa, 2010) to interpret hospital survey responses previously required in 
other studies to establish whether existing EHR met MU core standards as proscribed 
by the ONC. 
 This study utilized MU payment as the inclusion criteria for EHR adoption with 
MU standards.  To receive meaningful use payments, hospitals had to meet the 
predetermined Office of the National Coordinator (ONC) performance criteria and then 
“attest” to the technology adoption.  Through December 2015, Federal payments of 
$21,095,328,473 have been paid to all eligible providers with nearly $13 billion going to 
acute care hospitals (https://www.cms.gov/Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/Downloads/December2015_MedicareEH
RIncentivePayments.pdf). 
 The MU data file is the most current and accurate database of hospitals attesting 
to and being verified as meeting Meaningful Use standards as well as payments being 
issued based on performance  validation. This current study includes a sample of 4,221 
hospitals or 94% of hospitals nationwide. In comparison, the American Hospital 
Association annual survey of 4,474 acute care hospitals had an IT supplement 
response rate of 2,796, or 62.4%. This response rate while relatively high, results in a 
52 
 
loss of data for 1425 hospitals. As discussed in Chapter 5 this may have a material 
impact on accuracy and validity of the information. 
DESCRIPTION OF STUDY VARIABLES 
 Cost per Discharge 
 In order to assess the difference in cost per discharge between MU and non-MU 
hospitals, this study utilized standardized cost per discharge value from the CMS 
database publicly reported through Hospital Compare (www.hospitalcompate.gov). 
Importantly, this data file contains cost per discharge adjusted for unique characteristics 
of hospitals, historically identified as confounding variables preventing meaningful cost 
comparisons.  The formula adjusts for differences among hospitals in geographical 
location and in certain hospital-specific attributes.  The latter include higher costs of 
carrying on an approved teaching program, higher costs of care associated with a payer 
mix that includes a higher percentage of low-income Medicare and Medicaid patient 
populations, and special pass-through payments for unusual capital and other costs. 
This study utilized the specific hospital data to conduct a MU vs Non-MU cohort level 
comparison to assess cost impact in the value based purchasing context, no other study 
utilized this approach.   
Quality Outcomes 
 Under the Value Based Purchasing Program (Federal Register, 2011), CMS has 
tied performance on clinical outcomes to reimbursement.  The methodology employed 
in measuring clinical quality performance in this study is the analysis of risk adjusted 
mortality and readmission rates for three clinical conditions developed by CMS for 
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national reporting purposes from the outset of the program. The clinical conditions 
measured include: heart failure, community acquired pneumonia (pneumonia) and 
myocardial infarction (heart attack). In order to introduce this evolving approach to 
quality measurement, an underpinning is required to attempt to control the confounding 
factors and risk adjustment. The CMS database utilized to report facility outcomes has 
adopted a risk adjustment methodology that creates a level playing field for 
organizations to be compared to one another on this important outcome metric (Pitches, 
2007; Roberson, 2015).   
Safety Indicator  
 This study utilized Patient Safety Indicator 90 (PSI 90) an Agency for Healthcare 
Research and Quality composite value utilized by Hospital Compare website as a safety 
measure proxy measurement (www.qualityindicators.ahrq.gov/Modules/psi_resources).  
Importantly for comparison purposes, the measures of serious complications reported 
on Hospital Compare are risk adjusted to account for differences in hospital patients’ 
characteristics.  The rate for each PSI is calculated by dividing the actual number of 
outcomes at each hospital by the number of eligible discharges for that measure at 
each hospital, multiplied by 1,000.  The composite value reported on Hospital Compare 
(https://www.medicare.gov/hospitalcompare/data/serious-complications.html) is the 
weighted averages of the component indicators.   
Hospital Demographics 
 Endogenous variables that are associated with hospital performance (CMS, 
2014; Lin, 2014; Appari, 2012) were identified for each hospital included in the analysis.  
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These variables include hospital teaching status, hospital ownership category, and 
acuity of care, as measured by the case mix index (CMI), hospital region, and activity 
level as measured by annual discharges. Categorized by their MU status, each hospital 
individually and the respective hospital cohort (MU vs non-MU) performance were 
measured against its own performance for the baseline period 2009 versus 2013.    
DATA COLLECTION 
 The analytic sample was comprised of 4,221 non-federal acute care hospital U.S. 
hospitals using data reported from 2011 through 2013.  Data was drawn from three 
publicly reported national databases with respect to hospital’s technology status, costs 
and performance on publicly reported clinical outcomes, functional characteristics and 
demographics. 
 These databases are the only source utilized by CMS for reimbursement and 
public reporting purposes when determining which organization had achieved EHR 
implementation that meets MU standards, risk adjusted quality outcomes and 
identification of standardized costs controlling for multiple variables.  The majority of 
data utilized on the previous assessment of EHR adoption and its impact on quality, 
safety and cost by other large national studies (Appari, 2010; Ding, 2011; Agha, 2011, 
Himmelstein, 2009; Jones, 2014), relied either on self-reported survey data, non-risk 
adjusted clinical performance and cost report data that was not standardized for multiple 
hospital specific or regional variables. 
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DATA ANALYSIS 
Measurement Methodology 
 The Hospitals were assigned to control and treatment cohorts based upon their 
EMR adoption status. The respective hospitals unique Common Identification Number 
(CIN) number was used as a linking code to compile the information accurately from the 
3 publicly reported databases utilized for the study. Each hospital’s publicly reported 
performance data referred to above, for the respective pre and post MU attestation 
periods, was be obtained.   
 Due to the large number of hospitals, over 4000, wide geographic dispersion and 
other disparate attributes, the subject hospitals vary widely in numerous ways.  To 
identify and report on these variables each hospitals’ demographics profile information, 
most frequently associated with likelihood to adopt EHR technology was identified from 
the respective publicly reported data bases. These variables include: teaching status 
which identifies if the hospital trains residents, acuity which is measured as a function of 
case mix index, discharge volume measured as Medicare discharges and geographic 
regions. The hospital region was coded numerical as 1-4, to comply with the CMS 
methodology for identifying hospitals.    
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Figure 5.  The Four Medicare Regions 
Source: https://www.cms.gov/About-CMS/Agency-
Information/RegionalOffices/RegionalMap.html 
 The clinical outcome, safety and cost values all were risk adjusted to account for 
variations age, sex, severity of patient condition (CMI), indirect medical education cost 
associated with teaching status, operating expense associated with geographic location 
and payments for treating uninsured known as disproportionate share or DISH 
payments.   
 As stated above, all of the outcome measures selected were risk adjusted by the 
respective agency that reported the data, thereby normalizing the values across 
hospitals.  For the clinical outcomes the 3M risk adjustment methodology was utilized by 
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CMS.  For the standardized cost per discharge CMS developed an internal cost 
adjustment methodology in conjunction with statistical experts from Acumen LLC 
(http://www.qualitynet.org/dcs) and the Agency for Health care Research and Quality 
(AHRQ) devised the safety composite score approach 
(http://qualityindicators.ahrq.gov/Downloads/Modules/PSI/PSI_Composite_Developmen
t.pdf.)    
DATA ANALYSIS METHODS 
 This study used the publicly reported data available through the Office of the 
National Coordinator for MU status as well as the CMS clinical, cost and safety data set 
(https://data.medicare.gov/data/hospital-compare).  It separated the hospitals into MU 
and non-MU status and then combined each of the 4221 hospital’s risk adjusted 
outcome data and categorical variables into the master data set resulted in over 
287,000 data elements for analysis.  This robust data base combined with the risk 
adjustment scheme for the outcome indicators supported a unique and detailed 
statistical analysis of the difference in performance between MU and non-MU hospitals.   
 The statistical analysis was conducted on the outcomes of the two independent 
cohorts, MU and non-MU to establish whether there a difference between hospitals that 
implemented EMR and those that did not on important outcome variables.  The data 
was statistically analyzed utilizing SPSS version 22.  The analysis included: Levene's 
Test of Equality of Error Variances; Tests of Between-Subjects Effects; T-Test.  All of 
the data was analyzed at a minimum alpha of at least 0.05. 
58 
 
 Based upon these parameters a T-test is the appropriate statistical test.  It satisfies 
the following criteria: 
Assumption #1: The dependent variable is be measured on a continuous scale 
Assumption #2: The independent variable consists of two categorical groups. 
  The data analysis methodology includes both descriptive statistics and inferential 
statistical analysis.  Descriptive statistics in the form of frequencies, means, medians 
and standard deviations were constructed and utilized to examine specific 
characteristics of the hospital research population.  There is one independent variable 
- MU with two categories and eight dependent variables, analyzed separately. There are 
8 dependent variables: 3 readmission rates (heart attack, heart failure and pneumonia) 
and 3 mortality rates (heart attack, heart failure and pneumonia) a safety measure and 
the cost per hospital discharge.   
There are five descriptive variables for the sample (Teaching, region, ownership, acuity 
and number of discharges). The five categorical variables are not integrated into the 
research design.    
 This study was the first to gather “big data” utilizing publicly reported information 
which was not reliant on voluntary survey responses, included a standardized cost per 
discharge metric, without being reliant on a proxy measures gathered via voluntary 
survey responses to identify MU status.  Therefore, the results presented in the next 
chapter utilize a new lens with which to determine how electronic health records with 
MU capabilities impact cost, quality and safety. 
 
59 
 
Chapter IV 
RESULTS 
INTRODUCTION 
 The purpose of this study was to evaluate whether there is a difference in 
hospital performance between organizations that have adopted meaningful use of 
electronic health records and those that have not.  This chapter focuses on the 
statistical analysis of the data assembled on the outcomes of 4221 hospitals. 
CHARACTERISTICS OF THE SAMPLE 
 After the application of exclusion criteria, data was assembled on 4221 hospitals.  
There were 560 hospitals eliminated from the study because they had less than 50 
discharges per year, or less than at least 30 discharges per category of clinical 
performance.  Outcome measures were identified from publicly reported data sources, 
the performance year selected for study was 2013. 
 The profile of a hospital is comprised of demographic and operational 
characteristics.  These characteristics or endogenous variables (CMS, 2014; Lin, 2014; 
Appari, 2012) were identified for each hospital included in the analysis.  The variables 
include hospital teaching status, hospital ownership category, acuity of care as 
measured by case mix index (CMI), hospital region which was coded consistent with 
CMS regions and labeled 1-4 depending on state geography and activity level as 
measured by annual discharges.  In Table IV.  the teaching status, region and 
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ownership are illustrated for each of these characteristics in the respective cohorts, MU 
and non-MU. 
 
Table IV: Frequencies and Percentage of Total by Categorical Variables 
 
In the MU cohort, 2315 or 55% of hospitals had attested to MU by 2013.  
Seventy-one % or 1637 were non-teaching facilities, with the majority (40%) located in 
the South, followed by the Midwest, 29%, West and Northeast at 16% each.  The 
predominant ownership model was 61% voluntary, not for profit status, followed by 
governmental 23%, proprietary 18% and physician owned 1.5%. 
 For the non-MU cohort, 1906 or 45%, had yet to attest to MU.  Seventy eight % 
or 1490 were non-teaching facilities, with the majority (35%) located in the South, 
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followed by the Midwest, 30%, West 21% and Northeast at 11%.  The predominant 
ownership model was 60% voluntary, not for profit status, followed by governmental 
21%, proprietary 15% and physician owned 0.5%. 
DEPENDENT VARIABLE RESULTS 
 The differences in outcome performance between meaningful use (MU) and non-
meaningful use (Non-MU) hospitals were analyzed through T-Test.  The level of 
significance utilized was P =.05.  The dependent variables results describe mortality and 
readmission rates for heart failure, heart attack and pneumonia, cost per discharge and 
the AHRQ aggregate safety score.   
 In Table V.  the number of hospitals who reported by condition and the mean 
performance of the respective dependent variables is illustrated for all hospitals, MU 
and non-MU cohorts.  The “N” of each subset is a function of how many hospitals met 
reporting criteria per variable.  Minimum reporting thresholds were 30 discharges 
annually per condition.  What should be highlighted is that the difference in mean 
performance in mortality is consistently in favor of the MU hospitals, as is the difference 
in cost per discharge.  The readmission rate is lower for all three conditions in favor of 
the non-MU hospitals.  It must be noted that the readmission data is calculated as all-
cause readmission.  Therefore, readmission is not directly tied to the condition for which 
the patient was initially discharged from the hospital.  The PSI 90 or AHRQ safety score 
is identical between cohorts.  Further analysis of each variable and the statistical 
significance of the differences between cohorts will be described later in this chapter. 
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Table V: Mean Performance Data by Care, Cost and Safety Variables 
 
In Table VI.  the summary of the T-test results are depicted.  The mortality rates 
are listed consecutively for the 3 clinical conditions of interest, heart attack, heart failure 
and pneumonia.  A statistically significant difference in favor of the MU hospitals was 
identified for each condition.  For the readmission measure a statistically significant 
difference was found in favor of the non-MU hospitals.   With respect to cost, MU 
hospitals had a difference of $327 less per discharge using the CMS standardized 
discharge metric.  There was no difference between the hospital cohorts for the AHRQ  
safety score.  The following sections will describe in detail the clinical, cost and safety  
results for each condition illustrated in Table VI.    
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Table VI: T-test Results on Quality Variables by Meaningful Use Status 
 
RESULTS BY DEPENDENT VARIABLE 
The following analysis is ordered according to the research questions initialy presented 
in Chaper I. 
Heart Attack Mortality and Readmission 
 The research question was: Is there a difference in clinical outcomes between 
hospitals that have achieved Meaningful Use (MU) for their EHR systems verse 
hospitals that have not achieved MU as measured by mortality and readmission rate for 
Heart attack? 
 These results are reported from the CMS data base for Medicare discharges with 
a primary mortality cause (cause of death) of heart attack.  Medicare heart attack 
mortality rates were aggregated from 2510 hospitals that reported data. As illustrated in 
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Table VII and Figures 6 and 7, the overall national rate was 15.14%. The Non-MU 
hospital rate was 15.21% versus the MU hospital rate of 15.11%. This study found that 
there was a statisistically significant difference was in favor of the MU hospital (P<.041).   
A functional illustration of the implication of this finding would be its impact on 
overall deaths per 500 thousand admissions for the specific condition.  Nationally in 
2013 there were approximately 3,000,000,000 Medicare discharges for heart attack, 
heart failure and pneumonia.  With nearly 500,000 of these discharges for heart attack.  
There was an estimated reduction of 500 deaths in this condition associated with MU. 
 
Table VII: T-test Results on Heart Attack Mortality by Meaningful Use Status  
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Figure 6.  Histogram of Heart Attack Mortality Rate 2013 – Hospitals (MU=NO) 
 
Figure 7.  Histogram of Heart Attack Mortality Rate 2013 – Hospitals (MU=YES) 
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 The following readmission results are reported from the CMS data base for 
Medicare discharges. The patient has to have an initial or index admission of heart of 
heart attack. The case was categorized as readmission if the patient was readmitted 
within 30 days from the index admission with any diagnosis. This measurement is know 
as all-cause readmission rate and is how CMS calculates the metric.    
There were 2238 hospitals that reported on heart attack readmission rates, 1426 
were from the MU cohort amd 812 from the non-MU cohort.  As illustrated in Table VIII 
and Figures 8 and 9, the overall mean readmission rate was 18.31% with non-MU 
hospitals reporting a lower overall rate of 18.23 % versus the MU hospital rate of 
18.35%.  The difference was statisistically significant in favor of the non-MU hospital 
(P<.011).  In this condition with approximately 110,000 heart attack readmissions 
nationally at least 300 readmission were avoided.   
Table VIII: T-test Results on Heart Attack Readmission by Meaningful Use Status  
 
 
.   
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Figure 8.  Histogram of Heart Attack Readmit Rate 2013 – Hospitals (MU=NO) 
 
 
Figure 9.  Histogram of Heart Failure Readmit Rate 2013 – Hospitals (MU=YES) 
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Heart Failure Mortality and Readmission   
 The research question was: Is there a difference in clinical outcomes between 
hospitals that have achieved Meaningful Use (MU) for their EHR systems verse 
hospitals that have not achieved MU as measured by mortality and readmission rate for 
heart failure? 
 These results are reported from the CMS data base for Medicare discharges with 
a primary mortality cause (cause of death) of heart failure during the admission.  Heart 
failure mortality rates from 3625 hospitals were reported.  As illustrated in Table IX and 
Figures 10 and 11,  the overall national mortality rate was 11.81%.  The Non-MU 
hospital rate was 11.90% versus the MU hospital rate of 11.75%.  The difference was 
statistically significant in favor of the MU hospitals (P<.003).  With approximatelt 
1,200,000 heart failure discharges annually the reduced mortality associated with the 
benefit of MU adoption is approximately  2000 lives. 
Table IX: T-test Results on Heart Failure Mortality by Meaningful Use Status 
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Figure 10.  Histogram of Heart Failure Mortality Rate 2013 – Hospitals (MU=NO) 
 
 
Figure 11.  Histogram of Heart Failure Mortality Rate 2013 – Hospitals (MU=YES) 
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These results are reported from the CMS data base for Medicare discharges with 
an index admission of heart of heart failure.  The patient was categorized as 
readmission if they were reamitted within 30 days from the index admission with any 
diagnosis.  This measurement is know as all cause readmission rate and is how CMS 
calculates the metric.   In the heart failure readmission analysis there were 3693 
hospitals reporting data, 2156 were MU hospitals and 1538 were non-MU hospitals.  As 
illustrated in Table X and Figures 12 and 13, the overall national mean readmission rate 
was 23.06 % with non-MU hospitals reporting a lower overall rate of 23.00 % versus the 
MU hospital rate of 23.10%.  The difference was statisistically significant in favor of the 
non-MU hospital (P<.048).  The lower readmission rate was associated with 
approximately 330 less readmissions.   
Table X: T-test Results for Heart Failure Readmission by Meaningful Use Status 
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Figure 12.  Histogram of Heart Failure Readmit Rate 2013 – Hospitals (MU=NO) 
 
Figure 13.  Histogram of Heart Failure Mortality Rate 2013 – Hospitals (MU=YES) 
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The research question was: Is there a difference in clinical outcomes between 
hospitals that have achieved Meaningful Use (MU) for their EHR systems verse 
hospitals that have not achieved MU as measured by mortality and readmission rate for 
Pneumonia? 
These results are reported from the CMS data base for Medicare discharges with 
a primary mortality cause (cause of death) of pneumonia.   Pneumonia mortality rates 
were reported 3888 hospitals.  As illustrated in Table XI and Figures 14 and 15, the 
overall national mortality rate was 12.02%.  The Non-MU hospital rate was 12.14% 
versus the MU hospital rate of 12.04%.  The difference was statistically significant in 
favor of the MU hospital (P<.000).   With over 1,200,000 pneumonia discharges 
annually the reduced mortality associated with MU adoption is approximately 2400 lives. 
Table XI: T-test Results on Pneumonia Mortality by Meaningful Use Status 
 
 
 
73 
 
 
Figure 14.  Histogram of Pneumonia Mortality Rate 2013 – Hospitals (MU=NO) 
 
Figure 15.  Histogram of Pneumonia Mortality Rate 2013 – Hospitals (MU=YES) 
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These results are reported from the CMS data base for Medicare discharges with 
a primary admission cause of pneumonia.  The patient was categorized as readmission 
if they were reamitted within 30 days from the index pneumonia admission with any 
diagnosis.  This measurement is know as all cause readmission rate and is how CMS 
calculates the metric.    
 In the pneumonia readmission analysis there were 3900 hospitals reporting data, 
2221 were MU hospitals and 1679 were non-MU hospitals.  As illustrated in Table XII 
and Figures 16 and 17, the overall mean readmission rate was 17.61 % with non-MU 
hospitals reporting a lower overall rate of 17.54 % versus the MU hospital rate of 
17.66%.  The difference was statisistically significant in favor of the non-MU hospital 
(P<.004). 
Table XII: T-test Results on Pneumonia Readmission by Meaningful Use Status 
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Figure 16.  Histogram of Pneumonia Readmit Rate 2013 – Hospitals (MU=NO) 
  
Figure 17.  Histogram of Pneumonia Readmit Rate 2013 – Hospitals (MU=YES) 
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Patient Safety Composite Score 
 The research questions was: Is there a difference in clinical outcomes between 
hospitals that have achieved Meaningful Use (MU) for their EHR systems verse 
hospitals that have not achieved  MU as measured by Agency for Healthcare Research 
and Quality Patient Safety Indicator Measurement ? 
 For AHRQ composite safety score, 3163 hospitals reported data.  As illustrated 
in Table XIII and Figures 18 and 19, there were 1960 MU hospitals reorpting an overall 
score of 0.60 and 1203 non-MU hospitals reporting and identical score of 0.60.  there 
was no statstically significant difference between the MU and non-MU hospital 
outcomes.   
Table XIII: T-test Results on Composite Safety Score by Meaningful Use Status 
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Figure 18.  Histogram of Safety – Hospitals (MU=NO) 
 
Figure 19.  Histogram of Safety – Hospitals (MU=YES) 
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COST PER DISCHARGE 
 The research questions was: Is there a difference in cost per discharge between 
hospitals that have achieved Meaningful Use (MU) for their EHR systems verse 
hospitals that have not achieved as measured by the CMS standardized cost per 
discharge metric? 
 For the standardized cost per discharge there were 31634 hospitals reporting 
data.  As illustrated in Table XIV and Figures 20 and 21, the national mean Medicare 
discharge cost was $7975.   There were 1955 MU hospitals reporting with a mean 
discharge cost of $7852.  There were 1179 non-MU hospitals reporting with a cost per 
discharge of $8179.  The difference in mean cost per discharge was $327 in favor of 
MU hospitals which was statistically significant (P<.000).  With over 20,000,000 
Medicare discharges annualy an estimated cost reduction associated with MU is over 
$6 billion.  This very significant finding, the implicatiions of the cost of EHR adoption and 
potential future trajectory of savings associated with MU will be discussed in detail in 
Chapter 5.   
Table XIV: T-test Results on Standardized Cost Per Discharge Metric by Meaningful 
Use Status 
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Figure 20.  Histogram of Cost per Discharge – Hospitals (MU=NO) 
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Figure 21.  Histogram of Cost per Discharge – Hospitals (MU=YES) 
SUMMARY 
There are favorable mean scores for the Meaningul Use hospitals for heart 
failure, heart attack and pneumonia mortality.  In addition, the average standarized cost 
per discharge is lower for MU hospitals by $327.  There is no difference in mean safety 
score (PSI 90) between hospital cohorts.  The readmission results reveal that non-MU 
hospital had lower all-cause readmission rates in all three clinical domains.   While the 
differences are not large in comparing the raw rates when assessing the difference 
based upon the number of discharges impacted the number of lives saved and cost 
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reduced is substantial.  From the cost perspective wiith the cost per discharge 
difference of $327 and the 20,204,517 discharges included in the research, the dollars 
saved amount to over $6.6 billion.  In lives saved the data is likewise impactful.  When 
applying the improved mortality rate to the over 20,000,000 Medicare discharges from 
the nation’s hospitals a reduction in mortality of over 20,000 lives is associated with MU 
adoption.  The finding regarding readmission rates in favor of non-MU hospitals was 
unexpected. The phase1 MU guidelines are substantially focused on inter-facility 
integration and interoperability. As the phase 2 MU guidelines take hold with their focus 
on care plan integration, E-prescribing and related data sharing with external, non-
hospital providers, a positive impact on readmission rates is expected.  
Table XV illustrates the results for the Levene’s test.  The equality of variance 
test results were accepted for heart attack readmit and heart attack mortality rates, 
heart failure and pneumonia mortality rates.  The equality of variances results were 
rejected for heart failure and pneumonia readmission rates, safety and cost measures.  
In the cases where the equality of variance was rejected the alternate degrees of 
freedom and t-test scores were utilized to properly calculate statistical significance of 
the measurements.    
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Table XV: Levene’s Test for Equality of Variance of Quality Variables (2 sample t-test) 
 
 
Levene's Test for Equality of 
Variances 
F Sig. 
Heart Attack Readmit Rate  .939 .333* 
Heart Attack Mortality Rate  .310 .578* 
Heart Failure Readmit Rate  17.484 .000^ 
Heart Failure Mortality Rate  1.771 .183* 
Pneumonia Readmit Rate  9.830 .002^ 
Pneumonia Mortality Rate  .181 .670* 
Safety 9.093 .003^ 
Cost per Discharge 45.419 .000^ 
*equality of variance assumed    ^ equality of variance rejected 
+Equal variances not assumed for the t-test      
 ++Equal variances assumed for the t-test   
*p<.05   **p<.01 
 
 
 
83 
 
Chapter V 
DISCUSSION 
BACKGROUND 
 From a health policy perspective, the $50 billion CMS committed to the HITECH 
Act is a substantial investment in the implicit belief that EHR adoption will transform the 
U.S. healthcare system.  While the program’s stated purpose was to support and 
stimulate the adoption of EHRs’ in healthcare, addressing the value inequity between 
cost and outcomes in the $3 trillion U.S. healthcare system is an outcome of great 
interest (IOM, 2001).  Simultaneously, Value Based Purchasing, VBP, is realigning the 
reimbursement paradigm by shifting payments from fee for service to payment for value.  
In this scheme, outcome and cost are the respective numerator and denominator to 
measure value, inexorably linking these two initiatives (Porter, 2006). 
  Early studies undertaken to assess EHR impact on clinical and financial 
outcomes were primarily undertaken in the pre-MU era (Chaudry, 2006; Ding, 2011; 
Himmelstein, 2009; DesRoches, 2010).  Those studies used process measures to 
assess impact and cost estimates were generally derived from various sources such as 
cost reports, AHA survey responses, financial filings, etc.  The assessments of safety 
were generally focused on hospital centric studies on important indicators such as 
medication error, falls and infection rates (Bates, 2010; Poon, 2010).  Due to the 
complexity of identifying these outcomes from administrative data these results were 
difficult to validate and replicate across large numbers of organizations.  The need to 
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validate the interim progress that MU has on clinical outcomes and cost requires a 
revised measurement paradigm aligned with Value Based purchasing concepts of 
outcome and cost  (Porter, 2006) with a global focus on patient safety (AHRQ, 2006). 
The purpose of this research was to evaluate whether there is a difference in 
hospital performance outcomes in organizations that have implemented electronic 
health records that meet Meaningful Use (MU) standards.  The use of a revised 
measures paradigm, one focused on publicly reported outcome measures, not process 
indicators, is in alignment with payment reform under the Affordable Care Act.  The 
outcomes of interest, as stated, were mortality and readmission rates, cost per 
discharge and aggregate safety score.  With a national healthcare bill of over $3 trillion, 
the American healthcare system spends nearly double the amount of every 
industrialized nation on a per citizen basis.  Ironically, the U.S. has the lowest life 
expectancy and the highest infant mortality rate of the group (OECD, 2014).  In addition, 
the Institute of Medicine estimates that the third leading cause of death in America is 
related to patient safety lapses (Squire, 2012).  The need for a realignment of cost, 
outcome and patient safety is of paramount importance. 
This study sought to ascertain whether there is a relationship between 
Meaningful Use of EHRs’ and quality, cost and safety outcome measures.  In reviewing 
the study findings, after analyzing outcome data on 4221 hospitals the conclusion is that 
there is a statistical difference for mortality rates for all three conditions for meaningful 
use hospitals; heart attack, heart failure and pneumonia.  Further, meaningful use 
hospitals demonstrated statistically significant difference in terms of standardized cost 
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per discharge.  As discussed in greater detail later in this chapter, when extrapolating 
the mortality difference achieved at MU hospitals there were over 20,000 lives saved.  
This is a powerful finding and one further magnified when taken in the context that over 
$6 billion in cost per discharge was achieved by the same cohort (MU). 
These results are the first definitive endorsement of MU capability in clinical 
quality and cost savings.  When considering that the lead time for adopting complex 
technology is estimated at between two and five years (Ding, 2011), the fact that 
mortality differences and cost savings were demonstrated in the first two years after the 
initial attestation period, 2013, is support of the CMS investment.  Other potential 
explanations for outcomes improvements aside from MU implementation will be 
discussed later in this chapter. 
 
DISCUSSION 
Impact of the HITECH Act 
 The implementation of basic EHRs’ in the nation’s hospitals stood at just 8% in 
2008 (Jha, 2009).  With the passage of the HITECH Act in 2009, ushering in both 
monetary incentives and penalties for EHR adoption that had to meet MU standards, a 
veritable rush for implementation impacted the healthcare industry.  In fact by the time 
the first incentive payments were available in 2010-2011 period there was an over 
threefold increase of EHR adoption to nearly 27% of hospitals (DesRoches, 2013).  The 
initial uptake, according to the American Hospital Association annual IT survey, was in 
large, urban and teaching hospitals.  The research suggested that this hospital cohort, 
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large, urban, teaching hospitals, was twice as likely to have adopted an EMR and that 
approximately 44% could meet MU standards (DesRoches, 2013).  The AHA survey 
response rate at just over 60% did not include the many hospitals, at least 1500, and 
the actual results from this study discussed below differed materially. 
 By analyzing the actual 2013 MU attestation data file, the current study found 
that the percentage of hospitals that had actual MU certified EHRs’ had jumped from 
8% to 55%, or 2315 of 4221 hospitals nationally.  In contrast to the DesRoches (2013) 
study, the majority of hospitals that had actual MU certified functionality, 1637 of the 
2315, or 71% of the attesting cohort, were actually non-teaching facilities.   The majority 
(40%) located in the South, followed by the Midwest, 29%, West and Northeast at 16% 
each.  The predominant ownership model was 61% voluntary, not for profit status, 
followed by governmental 23%, proprietary 18% and physician owned 1.5%.  The 
difference in the data reported by DesRoches (2013) and the actual CMS data results 
just one year later may be interpreted in several ways. 
 One reason for the difference in actual versus reported uptake in MU certified 
EHRs s that the Desroches (2013) study relied on voluntary survey data with a 61% 
response rate.  A large number of hospitals, over 1500, did not reply, many of whom 
were likely not AHA members or have seen the value in completing the survey.  To 
receive MU payments it was mandatory for hospitals to attest and to be certified as MU 
compliant, therefore the CMS data file used for the current study had the most current 
and accurate data.   The other reason, also aligned with a  payment incentive, is that 
hospitals clearly moved very quickly, a 7 fold uptake, to advance their basic EHR 
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capability once the MU criteria was finalized in order to capitalize on the HITECH funds.  
Therefore the financial incentive seemed to have clearly increased the number of EHR 
installations by those meeting the criteria.  In the first year over $6 billion was awarded 
to hospitals. 
Clinical Quality  
           However, the most striking aspect of this study is that the clinical outcomes 
reported reveal statistically significant difference in mortality rates in all three clinical 
conditions, heart attack, heart failure and pneumonia for hospitals who achieved MU 
recognition for their EHR systems.  This critical finding represents both a quality and 
reimbursement benefit to hospitals.  The pressure to move away from fee for service 
reimbursement to value, driven by the VBP model has refocused the quality discussion 
to one centered on clinical outcomes and away from process measures.  Previous 
research (Ding, 2011; Appari, 2012; Himmelstein, 2009; Chaudry, 2006; Spencer, 2012) 
did not demonstrate this level of clinical improvement either in magnitude of change or 
uniformly across conditions.  It is important to discuss the focus on process versus 
outcome as a measurement paradigm in this prior research to understand the different 
outcomes of the studies.   
 The community standard for measurement of clinical quality since 2003 when the 
first publicly reported data by CMS (www.medicare.gov/hospitalcompare.gov) and the 
Joint Commission (www.JCAHO.org) has been the utilization of aggregated process 
measure data.  As discussed in the literature review, individual quality experts such as 
Donabedian (1988, 2003) as well as institutional authorities on quality measurement 
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such as the National Quality Forum, advocated for process measure standards.  
Indeed, the theoretical support for process measures is strong (Mant, 2001; Mainz, 
2003; Lilford, 2007).  However, the process measure philosophy is tied to the linkage 
between process and clinical standard validity and best suited for practitioner feedback 
and performance improvement.  However, the focus on population health inherent to 
VBP requires a measurement lens of broader scope and one oriented to informing wider 
aspects of health policy (Mant, 2001), that being outcomes.  Outcome measures such 
as mortality, readmission and infection are discrete events.  By focusing on mortality 
and readmission as quality endpoints, consistent with new VBP measures, this current 
study was able to report results less subject to such data management concerns (Mant, 
2001; Rubin, 2001).   
  Procedurally, the utilization of process measures requires data be abstracted 
from administrative systems.  This method is attractive since it is automated for large 
data sets, less expensive and efficient.  It does have validity issues, however, these 
limitations are a function of the completeness and accuracy of the individual 
documentation of each clinical intervention as transposed into the hospital record and 
billing systems (Billings, 2003; Grosse, 2010; Tollefson, 2011).  Each aggregate quality 
measure for the clinical conditions under study has at least 8 sub processes that must 
be performed and documented to achieve a “passing grade” for the clinical encounter.  
The variability of the documentation and data management associated with the process 
measures approach to quality measurement creates opportunity for error.  The outcome 
measure methodology utilized in the current study and discussed below alleviates these  
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Meaningful Use  
 Another issue requiring elaboration is the utilization of actual Office of National 
Coordinator (ONC) criteria to create the two cohorts used for analysis.  The research 
reported in this study utilized the ONC database of actual MU achievement utilized for 
awarding MU status and distribution of payments.  The information was validated and 
audited by CMS prior to awarding a MU certification or making payments.  All of the 
prior studies mentioned in the literature review utilized proxy measures based on either 
a Health Information Management Services Society (HIMSS) or AHA Information 
Technology voluntary survey instrument to establish if a hospital had implemented an 
EHR that was capable of meeting MU specifications.  These studies relied on self-
reported capabilities from either of the HIMSS or AHA hospital surveys.  The accuracy 
and response rate create a question as to the accuracy of categorizing a hospital in a 
specific cohort, MU or non-MU.  Further, as mentioned above in any given survey 
response year a large number of hospitals, over 1500, did not reply omitting a 
significant number of organizations from their analysis.  The impact of the inclusion of 
many non-surveyed hospitals in the current study significantly affected the true total of 
organizations meeting MU standards in the first 2 years, and affected how the cohort 
performed in the cost savings described below.    
Cost 
The fact that a statistically significant difference in cost per Medicare discharge between 
MU and non-MU hospitals of $327 was found in this study provides support for the $50 
billion investment of the HITECH Act.  In one year, with just over 50% of the nation’s 
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hospitals participating, the current study suggests over $6 billion in savings will have 
accrued from MU adoption.  The focus on whether EHRs’ demonstrated a relationship 
to cost in the $3 trillion U.S. healthcare system was a significant focus on this study.  
The pressure for policy change to create a value driven healthcare system under the 
American resource and Recovery Act (AARA) of 2009 was supported by economist 
Porter (2006).  CMS sought to bend the cost curve and align payment with value by 
implementing VBP and shifting the original reimbursement equation weighted 90% in 
favor of process to the current 2016 formula which is 90% outcome oriented 
(https://www.medicare.gov/hospitalcompare/data/total-performance-scores.html).   
 Prior studies have utilized various methods for detecting the impact of an EHR on 
hospital costs.  Himmelstein (2009) used Hospital Medicare Cost Reports to assess an 
organization’s overall administrative cost.  Ding (2011) used American Hospital 
Association survey data to create two financial indicators, operating cost per day and 
operating cost per admission.  DesRoches (2010) and Agha (2011) utilized Medicare 
Provider Analysis and Review File and Medicare Inpatient Impact File.  Other 
researchers excluded cost entirely choosing to focus on quality or utilization 
approaches, consistent with practice guidelines without commenting on costs (Jones, 
2014; Appari, 2012).  What is clear from the literature is that past studies utilized 
multiple approaches and data sources, some overlapping, others unique, utilized to 
assess if EHR adoption had an impact on healthcare costs.  This lack of consist 
measures limits the external validity of these studies on the cost domain. 
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 The difference with the current study is that none of the prior research utilized a 
normalized cost per discharge approach.  The current study used the CMS spending by 
claim file (www.data.medicare.gov/Hospital-Compare/Medicare-Hospital-Spending-by-
Claim) that calculates a normalized Medicare spending per discharge by hospital.  The 
multiple characteristics of a hospital’s overall cost structure, union versus non-union 
staff, urban versus rural, ownership models, payer mix, teaching status create such 
variability that without an adjusted cost per discharge approach there can be no 
meaningful cost comparison between the cohorts, MU and non-MU hospitals.  By 
utilizing the CMS Medicare spending per beneficiary file cost per discharge this barrier 
to cost analysis has been removed in this study.  This same standardized metric 
approach was utilized to assess the final and critically important safety domain. 
Safety 
The previous research on EHR impact on safety outcomes focused on specific 
initiatives in local hospital or health systems (Poon, 2012).  The seminal study To Err is 
Human (1999) identifying between 44-98,000 deaths annually from errors was followed 
by numerous other studies (Bates, 2001; Poon, 2010; Shekelle, 2011).  As identified in 
the cost per discharge issue, the study of safety and EHR impact on improving overall 
results were not undertaken on broad enough levels to create an endorsement of 
technology as the hoped for change agent. Some studies actually found that EHR 
created its own error prone process problems and a caution flag was raised (IOM, 2012; 
Sittig, 2012).  Few if any broad based studies were focused on this topic because of the 
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complexity in measuring and identifying agreed upon community standard for analysis. 
The AHRQ (2010) safety metric PSI 90, changed this barrier.   
Yet, while this new measurement paradigm was significant in its breadth of 
measurement and ability to be extracted from administrative data the results failed to 
reveal a difference in outcome between MU and non-MU hospitals in this study. One 
reason may be that the indicators selected for the composite score are not well aligned 
with clinical interventions that EHR can specifically impact. There are 11 indicators, 9 of 
which are surgery related, followed by pressure ulcers and blood stream infection. In 
order to better assess the impact of EHR on patient safety a different indicator set more 
effective in impacting safety issues such as medication errors, timing of antibiotic for 
procedures, pneumonia care or management of sepsis (Bates, 2001; Poon, 2010) 
would be more sensitive measures. 
THEORETICAL IMPLICATIONS 
 This study drew upon two theoretical frameworks, one focused on clinical care 
measurements and the other focused on healthcare economics.  The Donabedian 
Model focuses on the structure, process and outcome to measure quality.  The second 
was the Value Based Purchasing theory advanced by economist Michael Porter in his 
seminal work, Redefining Healthcare (2006). The Porter model argues that the US 
healthcare system’s inherently misaligned payment methodology resulted in the pursuit 
of high volume, high margin services without a focus on the outcomes of health for the 
population being served or the total cost of care incurred.   
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The Donabedian quality measurement theory remains a consistently applied and 
valid approach to measuring quality from a process perspective.  The CMS hospital 
compare program, Joint Commission and National Quality Forum utilize and endorse 
quality measurement at the process level.  However, the measurement framework is 
best applied at the practice feedback level.  For example assessing performance and 
giving feedback re compliance with or missed care opportunities, such as administration 
of therapy within proscribed time frames such as aspirin within 60 minutes for heart 
attack patient, antibiotic within 30 minutes for pneumonia patients in the ER.  Mainz 
states simply “process indicators assess what the provider did for the patient and how 
well, it was done” (p.  525).This approach is in contrast to outcome measures with their 
focus on population and endpoint measurement. 
Process measures are at best useful in a Pay-for-Performance approach such as 
the Premier/CMS Project (Lindenauer, 2007) that aligned payment with achieving the 
highest levels of compliance with care guidelines.  It was ultimately concluded that the 
program improved compliance but never decreased cost, reduced safety errors, or 
changes endpoints in mortality or readmission.  So while the process measurement 
theory remains a valid and useful tool in quality improvement efforts, for the purposes of 
validating broader population measures such as mortality rates, readmission and safety 
metrics the greater the relevance of outcome measures (Mainz, 2003).  Most 
importantly however, process measurement is methodologically unsuitable for 
measuring outcomes and hence out of sync with the Value Based Purchasing 
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reimbursement paradigm implemented by CMS where 90% of current payments are 
focused on outcome and not process measures.   
LIMITATIONS 
 As with all studies, this study has several limitations.  First, hospitals cannot be 
randomly assigned to control and treatment groups as in a randomized control trial but 
they could be assigned to cohorts based upon their EMR adoption status.  Due to the 
large number of hospitals, 4221, resulting in wide geographic dispersion and other 
disparate attributes, the subject hospitals vary widely in numerous ways: teaching 
status, urban vs rural, large vs small discharge volume, union status and related social 
determinants of patients.  This is a potential threat to the generalizability of the study 
conclusions.  To control for this threat, all of the outcome measures selected were risk 
adjusted thereby normalizing the values across hospitals. 
 The data utilized for this study was abstracted from sources that utilized 
administrative data.  As discussed above there are inherent limitations to this data 
source, however, outcome measures such as mortality, readmission and infection are 
discrete events.  By focusing on mortality and readmission as quality endpoints, 
consistent with new VBP measures, this study was able to report results less subject to 
such data management concerns.  In addition, the 3M risk adjustment methodology 
applied by CMS for the clinical outcome measures while the current standard for risk 
adjustment in the industry is subject to the criticism of all such formulas (Rubin, 2001).  
The standardized cost metric utilized for assessing cost per discharge was developed 
by CMS.  The cost is calculated from hospital specific data and then risk adjusted for a 
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number of variables, medical education, geographic cost allowances, etc.  affecting a 
hospital’s operating expense (https://www.cms.gov/Medicare/Quality-Initiatives-Patient-
Assessment-Instruments/hospital-value-based-purchasing/Downloads/).  As such this 
metric is prone to all criticisms that any risk adjusted value may be subject.  The actual 
cost savings calculated in this study is based upon this value and may not be directly 
linked to actual reduced hospital operating expenses.  It is also focused solely on 
standardized hospital discharge cost not total cost of care per episode attributable to the 
population. 
FUTURE RESEARCH 
 This study was undertaken to focus a lens on EHR adoption, a major health 
policy initiative under the HITECH Act (2009).   The $50 billion investment was aimed at 
transforming healthcare by accelerating the adoption of EHRs.  Future research is 
required to assess the ongoing impact EHR adoption under MU guidelines will have on 
clinical, cost and safety outcomes as larger and larger numbers of hospitals meet the 
requirements or face penalties.  This is especially true as Meaningful Use Phase 2 
places greater focus on connectivity between providers, E-prescribing, care plan 
exchange, greater utilization of evidence based guidelines and patient engagement via 
portal use is now being implemented. 
 As more care is being directed toward lower cost settings, the ambulatory care 
platform will assume greater importance in overall healthcare spending.  Therefore, 
future research could include additional studies aimed at evaluating how and if, the 
increasing adoption of EHR by non-hospital providers such as physician practices, 
96 
 
therapist offices, nursing homes, home care agencies, pharmacies and other ancillary 
providers has the potential to result in increased clinical and cost benefits.  Specifically,  
a focused examination of how readmission within 30 days of an index hospitalization 
can be impacted by EHR adoption and interoperability when the constellation of 
providers mentioned above have facilitated electronic communication. 
 Another area requiring future research is the continued refinement of patient 
safety indicators that can be measured within the EHR platform of hospitals and other 
providers.  This study utilized the AHRQ, PSI 90 patient safety composite score which 
revealed no significant difference between the cohorts under study.  Their appeared to 
be low sensitivity between the indicators that comprise the score to processes that are 
affected most directly by EHR functionality, i.e. medical management versus surgical 
interventions.   
 The issue of cost continues to be a prominent one in discussing the future state 
of the U.S. healthcare system.  Future research that identifies the impact of specific 
EHR functionality on total cost of care is required to identify, refine and expand the 
functionality that maximizes the cost benefit of healthcare dollars expended.   
  As noted earlier, legislation affecting both the community physician practices 
and hospitals under the Medicare Access and CHIP Reauthorization Act released in 
April of 2016 is focused on how adoption and outcomes should be aligned with payment 
reform.  In the new reimbursement paradigm payment for value not volume is an 
underpinning of healthcare transformation (Porter, 2006).  Therefore, further research is 
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required to see how these intersecting forces, EHR systems and VBP, impact a new era 
in which fee for service medicine recedes payment for value ascends. 
 
CLOSING COMMENTS-FUTURE INDUSTRY TRENDS 
 The future improvement in the healthcare system will require additional 
cooperation and integration between hospitals, community based providers, continuing 
care organizations, home care agencies, ancillary testing providers and others.  The 
electronic health record information linkages between the providers, the payers, and 
oversight agencies are critical to improving quality outcomes, and reducing overall cost 
of care.  The infrastructure of the National Health Information Network may be a 
powerful tool in this pursuit. 
 At the center of all of this change is the patient.  For change to be meaningful 
and lasting, culturally competent care must be provided to patients by a competent 
workforce motivated to improvement.  Technology, including EHR, is a tool that can 
support these efforts and the evidence assembled by this study suggests that it is a 
powerful one.  As discussed above, future research is required to understand the 
implications of EHR in conjunction, not in isolation, of other initiatives.  Improvements in 
hospital outcomes of care are a national responsibility of the healthcare system from a 
regulatory, professional and fiduciary perspective. 
 In conclusion, this study found that there is a positive difference in cost per 
discharge and clinical outcomes between hospitals that have and have not adopted MU 
technology in their day to day operations.  As concepts of interoperability between 
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hospitals, physician practices and out-patient providers advance in the next stage of MU 
implementation more gains are possible.  Based on the current study over 21,000 lives 
were saved and up to $6.6 billion dollars in expenditure avoided related to MU 
implementation.  As the remaining hospitals across the nation close the gap in adopting 
EHRs’ with MU functionality further benefits may accrue if this trajectory of improvement 
holds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
 
REFERENCES 
Appari, A., Eric Johnson, M.  and Anthony, D.  L.  (2012), Meaningful use of     
electronic health record systems and process quality of care:  evidence from a panel 
data analysis of U.S.  acute-care hospitals.   Health Services Research, doi: 
10.1111/j.1475-6773.2012.01448.x doi: 10.1111/j.1475-6773.2012.01448.x 
 
Bates, D., Cohen, M., Leape, L., Overhage, M., Shabot, M., Sheridan, T.    
(2001).    Reducing the Frequency of Errors in Medicine Using Information 
Technology.   Journal of the American Medical Informatics  Association, 8(4), 299–
308. 
 
Brenna, T., et al.   Incidence of adverse events and negligence in hospitalized 
patients: results of the Harvard Medical Practice Study.  Qual SafHealth 
Care 2004;13:145–152 
 
Byrne, C., Pan, E., Vincent, A., Johnston, D., Middleton, B.  (2010). The value from 
investments in health information technology at the U.S.  department of veterans 
Affairs.  Health Affairs, 29(5), 629-638. 
 
Chaudry, B., Wang, J., Wu, S., Maglione, M., Mojica, W., Roth, E.,   
Shekelle, P.  (2006).   Systematic review: impact of health information technology on 
quality, efficiency, and costs of medical care.  Annals of Internal Medicine, 742-751. 
 
Roadmap for Implementing Value Driven Healthcare in the Traditional  
Medicare Fee-   for-Service Program.   
https://www.cms.gov/.../VBPRoadmap_OEA_1-16_508.pdf 
 
Davis, K., Schoen, C.., Schoenbaum, S., Doty, M., Holmgren, A.., Kriss, J., 
Shea, K.   (2007) Mirror, Mirror on the Wall: An International Update on the 
Comparative Performance of American Health Care.  Common Wealth Fund.   
Volume 59. 
 
Ding, D., Xiaoseng, D.  (2011) Long-term effects of electronic medical records  
on hospital clinical, financial and operational performance.  POMS  
100 
 
Conference Proceedings, Abstract number: 025-0837. 
 
Donabedian, A.  (1988) The quality of care How can it be measured? Journal  
American Medical Association, 1743-1748. 
 
Federal Register.  (2011)  Hospital Value-Based Purchasing Program (CMS- 
3239-F) 
 
Himmelstein, D., Wright, A., Woolhandler, S.   (2009).  Hospital computing and  the 
costs and quality of  care: A national study.   The American Journal of Medicine, 1-
7.         
 
Institute of Medicine.   (1999).  To Err is Human: Building a Safer Health 
System.   Washington DC: Author. 
 
Institute of Medicine.   (2001).  Crossing the Quality Chasm:  A New Health 
System for the 21st Century.  Washington DC: Author.   
 
Jha, A., Desroches, C., Campbell, E., Donelan, K., Rao, S., Ferris, T.,  
Blumenthal, D.  (2009).  Use of electronic health records in U.S.  hospitals.   The 
New England Journal of Medicine, 1628-1638.    
 
Lilford, R., Brown, C., Nicholl, J.  Use of process measures to monitor the  
quality of clinical practice (2007).  British Medical Journal, 648-650. 
 
Lin, Y., Lin, M., Chen, H.  (2014) Beyond Adoption: Does Meaningful  
Use of EHR Improve Quality of Care? Social Research Science Network.  
http://ssm.com/abs tract=2444054 
 
Lindenauer, P., Remus, D., Roman, S., Rothberg, M., Bratzler, D.  (2007). 
Public reporting and pay for performance in hospital quality improvement.   
The New England Journal of Medicine, 486-496.    
 
Mainz, J.  (2003) Defining and classifying clinical indicators for quality  
101 
 
improvement.   International Journal for Quality in Health Care, 523-530. 
 
Mant, J.  (2001).  Process versus outcome indicators in the assessment of  
quality health care.  International Journal for Quality in Health Care, 475- 
480. 
 
Poon, E., Keohane, C., Yoon, C., Ditmore, M., Bane, A., Levtzion-Korach, O.,   
Gandhi, T.   (2010).  Effect of Bar-Code Technology on the Safety of  
Medication Administration.  New England Journal of Medicine, 1698-1707.    
 
Pronovost, P., Nolan, T., Zeger, S., Miller, M., Rubin, H.  (2004) How can 
clinicians measure safety and quality in acute care? The Lancet, 1061-   
1067. 
 
Research-Statistics-Data-and-Systems/Statistics-Trends-and 
Reports/NationalHealthExpendData/Downloads/highlights.pdf;  
www.cms.gov.(2014) 
 
Shekelle, P.  & Jones, S.  Health Information Technology: An Updated  
Systematic Review with a Focus on Meaningful Use Functionalities.   
(2014) Rand Corporation Prepared for: Office of the National  
Coordinator for Health Information Technology 
 
Spencer, J., Adams, J., Schneider, E., Ringel, J., McGlynn, E.  (2010)  
Electronic health record adoption and quality improvement in US 
hospitals.  American Journal of Managed Care, SP-64-SP71. 
 
Wang, S., Middleton, B., Prosser, L., Bardon, C.  Spurr, C., Carchidi, P.,  
Bates, D.  (2003).  A cost benefit analysis of electronic medical records in primary 
care.   The American Journal of Medicine, 397-403.             
 
 
 
102 
 
APPENDIX A 
Seton Hall University: Institutional Review Board (IRB) Approvals 
 
 
 
 
 
 
 
 
 
 
103 
 
 
104 
 
 
APPENDIX B 
DEFINITIONS 
ARRA – American Recovery and Reinvestment Act 2009, is the parent legislation that 
authorized the funds for electronic health record subsidy for the HITECH Act 
AHRQ - Agency for Healthcare Research and Quality is a fully funded division of the 
Department of Health and Human Services.  Their stated mission is “The Agency for 
Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make 
health care safer, higher quality, more accessible, equitable, and affordable, and to 
work within the U.S.  Department of Health and Human Services and with other partners 
to make sure that the evidence is understood and used” 
(http://www.ahrq.gov/cpi/about/mission/index.html) 
CMS – Center for Medicare and Medicaid Services.  CMS is a federal agency that 
administers health insurance programs for 100 million Americans.  CMS sponsors the 
healthcare website, www.cmshospitalcompare.gov that provides a portal into healthcare 
services rating hospital and provider performance.   
EHR system– Electronic Health Record refers to a system of interconnected electronic 
health care record platforms.  These systems create a platform and repository for such 
functions as physician order entry, nursing record keeping, pharmacy, radiology, 
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surgery and anesthesia charting, ER and Transport systems.  The system is capable of 
having a outward facing portal for patient engagement, transfer of care plans and 
discharge information to providers outside the hospital such as nursing homes as well 
as connecting to local and national Health Information Exchanges.   
HITECH Act - Health Information Technology for Economic and Clinical Health Act was 
enacted under the ARRA legislation specifically to spur adoption of EHRs.  The HITECH 
Act set Meaningful Use of interoperable EHRs systems as a critical national goal and 
incentivized EHR adoption.  Penalties for non-adoption were also a part of the program.   
Interoperability – The complex US health care system is comprised of numerous 
electronic health record (EHR) products.  Interoperability refers to the architecture or 
standards that make it possible for diverse EHR systems to work compatibly in a true 
information network exchanging information between providers. 
Meaningful Use - The Meaningful Use aspect of the HITECH Act is part Medicare and 
Medicaid EHR Incentive Programs that sets out specific performance and compliance 
criteria for providers to demonstrate that their certified EHR technology meets specific  
measurement thresholds that range from recording patient information, accessing 
clinical evidence, patient portal, external data transmission, syndromic surveillance 
capability all as structured data. 
Mortality – is a measure that calculates actual death during a hospital stay, it does not 
include hospice services.  For this study the data is risk adjusted, it does include 
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hospitalizations for Medicare beneficiaries 65 or older who were enrolled in Medicare for 
12 months before their hospital admission. 
Readmission - measures that are calculations of unplanned readmission to an acute 
care hospital in the 30 days after discharge from a hospitalization.  Patients may have 
had an unplanned readmission for any reason.  For this study the data are risk adjusted.  
(https://www.medicare.gov/HospitalCompare/Data/30-day-measures.html) 
Risk adjustment- To accurately compare hospital performance, the CMS readmission 
and death measures adjust for patient characteristics that may make readmission or 
death more likely.  These characteristics include the patient’s age, past medical history, 
and other diseases or conditions known as comorbidities the patient had when they 
were admitted that are known to increase the patient’s chance of dying or having an 
unplanned readmission.( https://www.medicare.gov/HospitalCompare/Data/30-day-
measures.html) 
VBP - Hospital Value-Based Purchasing (VBP) is part of the Centers for Medicare & 
Medicaid Services’ (CMS’) effort to link Medicare’s payment system to a value-based 
system to improve healthcare quality, including the quality of care provided in the 
inpatient hospital setting.  The program attaches value-based purchasing affecting 
payment for inpatient stays in over 3,500 hospitals across the country.  Participating 
hospitals are paid for inpatient acute care services based on the quality of care, not just 
quantity of the services they provide.  Congress authorized Inpatient Hospital VBP 
107 
 
under the Affordable Care Act.  (https://www.cms.gov/Medicare/Quality-Initiatives-
Patient-Assessment-Instruments/hospital-value-based-purchasing/index.html) 
 
